FDA to Drug Sponsors: Ensure Data Is ‘Interoperable or Integrated’

Drug sponsors and investigators should work with organizations that offer either interoperable or integrated electronic health records or electronic data capture systems, the FDA said in a final guidance.
Source: Drug GMP Report